4,350 Shares in Oscar Health, Inc. $OSCR Acquired by Ameritas Advisory Services LLC

Ameritas Advisory Services LLC purchased a new position in shares of Oscar Health, Inc. (NYSE:OSCR) in the second quarter, HoldingsChannel.com reports. The fund purchased 4,350 shares of the company’s stock, valued at approximately $93,000.

A number of other institutional investors and hedge funds have also modified their holdings of the business. Vanguard Group Inc. raised its stake in shares of Oscar Health by 3.7% during the first quarter. Vanguard Group Inc. now owns 19,698,442 shares of the company’s stock worth $258,247,000 after buying an additional 700,469 shares during the last quarter. T. Rowe Price Investment Management Inc. raised its stake in shares of Oscar Health by 4.1% during the first quarter. T. Rowe Price Investment Management Inc. now owns 11,826,245 shares of the company’s stock worth $155,043,000 after buying an additional 467,301 shares during the last quarter. Thrive Capital Management LLC raised its stake in shares of Oscar Health by 33.4% during the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock worth $85,258,000 after buying an additional 1,588,395 shares during the last quarter. BIT Capital GmbH raised its stake in shares of Oscar Health by 1.1% during the first quarter. BIT Capital GmbH now owns 4,521,445 shares of the company’s stock worth $59,276,000 after buying an additional 47,592 shares during the last quarter. Finally, Glynn Capital Management LLC raised its stake in shares of Oscar Health by 14.0% during the first quarter. Glynn Capital Management LLC now owns 3,115,217 shares of the company’s stock worth $40,840,000 after buying an additional 381,980 shares during the last quarter. 75.70% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

OSCR has been the subject of a number of recent research reports. Baird R W downgraded shares of Oscar Health from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 25th. Wells Fargo & Company boosted their price objective on shares of Oscar Health from $10.00 to $14.00 and gave the company an “underweight” rating in a report on Tuesday. UBS Group restated a “sell” rating and set a $11.00 price objective (down previously from $15.00) on shares of Oscar Health in a report on Tuesday, July 15th. Robert W. Baird restated a “neutral” rating and set a $14.00 price objective (down previously from $28.00) on shares of Oscar Health in a report on Friday, July 25th. Finally, Weiss Ratings restated a “sell (d)” rating on shares of Oscar Health in a report on Wednesday. Four equities research analysts have rated the stock with a Hold rating and six have given a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Strong Sell” and a consensus price target of $12.64.

Oscar Health Stock Performance

Shares of OSCR opened at $18.81 on Friday. Oscar Health, Inc. has a 12 month low of $11.20 and a 12 month high of $23.80. The firm has a fifty day simple moving average of $17.77 and a 200 day simple moving average of $15.85. The stock has a market capitalization of $4.86 billion, a price-to-earnings ratio of -23.22 and a beta of 1.89. The company has a current ratio of 0.86, a quick ratio of 0.86 and a debt-to-equity ratio of 0.26.

Oscar Health (NYSE:OSCR) last announced its earnings results on Wednesday, August 6th. The company reported ($0.89) EPS for the quarter, topping the consensus estimate of ($0.90) by $0.01. The business had revenue of $2.86 billion during the quarter, compared to analysts’ expectations of $2.88 billion. Oscar Health had a negative net margin of 1.50% and a negative return on equity of 13.78%. The firm’s revenue was up 29.0% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.20 earnings per share. Research analysts forecast that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.

Insider Buying and Selling

In other Oscar Health news, insider Mario Schlosser sold 395,000 shares of the stock in a transaction on Monday, September 22nd. The shares were sold at an average price of $18.43, for a total value of $7,279,850.00. Following the completion of the sale, the insider owned 501,148 shares in the company, valued at $9,236,157.64. This trade represents a 44.08% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. 24.39% of the stock is currently owned by corporate insiders.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.